title: Molecular radiobiology: the state of the art.
abstract: Traditional cytotoxic agents used in cancer therapy were initially discovered based on their ability to kill rapidly dividing cells. The targets of these early-generation agents were typically one or more aspects of DNA synthesis or mitosis. Thus, dose-limiting toxicities commonly associated with these agents include GI dysfunction, immunosuppression, and other consequences of injury to normal tissues in which cells are replicating under normal physiologic conditions. Although many of these agents still play an important role in cancer therapy when given concurrently with radiation therapy, the major thrust of radiobiology research in the last two decades has focused on discovering tumor-specific traits that might be exploited for more selective targeting that would enhance the efficacy of radiotherapy with less normal tissue toxicity. These newer generation molecular targeted therapies interfere with the growth of tumor cells by inhibiting genes and their protein products that are needed specifically by the tumor for survival and expansion. These agents can be complementary to radiotherapy, a spatially targeted agent. Although there have been extraordinary technical advances in radiotherapy in recent years, we are reaching the limits of improvements that radiotherapy delivery technology can bring and need different approaches. This review will highlight promising new tumor biology-based targets and other novel strategies to reduce normal tissue injury, increase tumor control, and expand the use of radiotherapy to treat widespread metastatic disease.
authors.affiliation: Stanford University School of Medicine, Stanford, CA. giaccia@stanford.edu.
authors.forename: Amato J
authors.initials: AJ
authors.lastname: Giaccia
mesh_terms: D006801:Humans; D009369:Neoplasms / Q000235:genetics / Q000473:pathology / Q000532:radiotherapy*; D057285:Precision Medicine / Q000379:methods; D011853:Radiobiology / Q000379:methods*
references.citation: Cancer Chemother Pharmacol. 2010 Mar;65(4):791-801
references.pmid: 20012293
references.citation: J Clin Invest. 2008 Dec;118(12):3930-42
references.pmid: 19033663
references.citation: Nat Rev Cancer. 2007 Dec;7(12):949-60
references.pmid: 18034185
references.citation: Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):293-5
references.pmid: 22560555
references.citation: IUBMB Life. 2012 Feb;64(2):109-19
references.pmid: 22162139
references.citation: Antioxid Redox Signal. 2014 Jul 10;21(2):338-55
references.pmid: 24147585
references.citation: J Clin Oncol. 2010 Jun 20;28(18):2989-95
references.pmid: 20479425
references.citation: J Clin Oncol. 2014 Sep 10;32(26):2902-12
references.pmid: 25113765
references.citation: Annu Rev Biochem. 1996;65:241-69
references.pmid: 8811180
references.citation: Clin Ther. 1996 May-Jun;18(3):360-71; discussion 359
references.pmid: 8829014
references.citation: Strahlenther Onkol. 2005 Aug;181(8):507-14
references.pmid: 16044218
references.citation: Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9141-5
references.pmid: 8090782
references.citation: Nat Rev Cancer. 2011 Oct 24;11(11):805-12
references.pmid: 22020206
references.citation: Science. 1999 Sep 10;285(5434):1733-7
references.pmid: 10481009
references.citation: Acta Oncol. 1995;34(3):313-6
references.pmid: 7779415
references.citation: Sci Transl Med. 2011 Aug 3;3(94):94ra70
references.pmid: 21813754
references.citation: Toxicology. 2003 Jul 15;189(1-2):1-20
references.pmid: 12821279
references.citation: Int J Oncol. 2009 Sep;35(3):609-15
references.pmid: 19639181
references.citation: Nat Clin Pract Oncol. 2005 Jan;2(1):34-9
references.pmid: 16264854
references.citation: Science. 2010 Jan 29;327(5965):593-6
references.pmid: 20019247
references.citation: Cell Cycle. 2006 Jun;5(12):1258-61
references.pmid: 16760649
references.citation: Drugs. 1995 Dec;50(6):1001-31
references.pmid: 8612469
references.citation: Cancer Res. 2010 Apr 1;70(7):2984-93
references.pmid: 20233878
references.citation: Science. 2001 Jul 13;293(5528):293-7
references.pmid: 11452123
references.citation: Blood. 2008 Dec 15;112(13):4808-17
references.pmid: 19064740
references.citation: Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):1051-61
references.pmid: 11429233
references.citation: J Clin Oncol. 2008 Aug 1;26(22):3785-90
references.pmid: 18591545
references.citation: Int J Breast Cancer. 2013;2013:659723
references.pmid: 24416595
references.citation: J Surg Oncol. 2008 Sep 1;98(3):202-6
references.pmid: 18618604
references.citation: N Engl J Med. 2012 May 24;366(21):2035; author reply 2035-6
references.pmid: 22621637
references.citation: Int J Radiat Oncol Biol Phys. 2001 Oct 1;51(2):474-7
references.pmid: 11567823
references.citation: Cancer Res. 2003 Jun 15;63(12):3413-7
references.pmid: 12810678
references.citation: Cancer Res. 1990 Jan 1;50(1):97-102
references.pmid: 2403420
references.citation: Transplantation. 2012 Feb 27;93(4):342-7
references.pmid: 22082820
references.citation: Expert Opin Ther Pat. 2010 Sep;20(9):1219-45
references.pmid: 20698812
references.citation: Lancet Oncol. 2010 Jan;11(1):21-8
references.pmid: 19897418
references.citation: Neuro Oncol. 2013 Feb;15(2):172-88
references.pmid: 23258846
references.citation: Radiother Oncol. 2013 Sep;108(3):446-50
references.pmid: 23891087
references.citation: Acta Oncol. 2013 Jun;52(5):1002-9
references.pmid: 22950385
references.citation: Int J Radiat Oncol Biol Phys. 2001 Oct 1;51(2):494-506
references.pmid: 11567826
references.citation: J Natl Cancer Inst. 2013 Feb 20;105(4):256-65
references.pmid: 23291374
references.citation: Clin Cancer Res. 2013 Dec 15;19(24):6741-50
references.pmid: 24141625
references.citation: Nat Rev Cancer. 2004 Sep;4(9):737-47
references.pmid: 15343280
references.citation: Neuro Oncol. 2011 Mar;13(3):298-306
references.pmid: 21339191
references.citation: Sci Transl Med. 2014 May 14;6(236):236ra64
references.pmid: 24828078
references.citation: Science. 2008 Apr 11;320(5873):226-30
references.pmid: 18403709
references.citation: J Clin Oncol. 2009 Jul 10;27(20):3297-302
references.pmid: 19487376
references.citation: Int J Radiat Oncol Biol Phys. 1996 Apr 1;35(1):103-11
references.pmid: 8641905
references.citation: N Engl J Med. 2005 Jul 14;353(2):172-87
references.pmid: 16014887
references.citation: Clin Cancer Res. 2010 Sep 15;16(18):4553-60
references.pmid: 20823145
references.citation: N Engl J Med. 2012 Mar 8;366(10):925-31
references.pmid: 22397654
references.citation: Sci Rep. 2012;2:362
references.pmid: 22500211
references.citation: Int J Radiat Oncol Biol Phys. 1990 Apr;18(4):849-59
references.pmid: 2182580
references.citation: J Clin Oncol. 2014 Sep 10;32(26):2886-93
references.pmid: 25113770
references.citation: Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1214-9
references.pmid: 21514075
references.citation: Nat Rev Drug Discov. 2011 May;10(5):351-64
references.pmid: 21532565
references.citation: Mol Cancer Res. 2008 Apr;6(4):517-24
references.pmid: 18403632
references.citation: Free Radic Biol Med. 2008 Feb 1;44(3):322-31
references.pmid: 18215740
references.citation: Mol Cell Biol. 2004 Oct;24(19):8504-18
references.pmid: 15367671
references.citation: Cancer Res. 1999 Dec 1;59(23):5871-4
references.pmid: 10606225
references.citation: Sci Transl Med. 2012 Jun 6;4(137):137ra74
references.pmid: 22674552
references.citation: Br J Cancer. 2013 May 28;108(10):2021-32
references.pmid: 23632475
references.citation: Semin Radiat Oncol. 2004 Jul;14(3):198-206
references.pmid: 15254862
references.citation: Science. 1988 Feb 5;239(4840):645-7
references.pmid: 3277276
references.citation: Nat Rev Cancer. 2012 Mar 22;12(4):252-64
references.pmid: 22437870
references.citation: Br J Pharmacol. 1980 Oct;70(2):219-27
references.pmid: 6159029
references.citation: J Clin Oncol. 2006 May 1;24(13):2098-104
references.pmid: 16648512
references.citation: Future Oncol. 2010 Jan;6(1):127-48
references.pmid: 20021214
references.citation: Cancer Res. 2008 Jan 15;68(2):605-14
references.pmid: 18199558
references.citation: Semin Radiat Oncol. 2013 Oct;23(4):273-80
references.pmid: 24012341
references.citation: Semin Radiat Oncol. 2001 Oct;11(4):281-9
references.pmid: 11677653
references.citation: Clin Cancer Res. 2002 May;8(5):1065-72
references.pmid: 12006520
references.citation: Clin Adv Hematol Oncol. 2008 Oct;6(10):742-50
references.pmid: 18997665
references.citation: N Engl J Med. 2006 Feb 9;354(6):567-78
references.pmid: 16467544
references.citation: J Biomol Screen. 2014 Apr;19(4):538-46
references.pmid: 24464432